LONDON (Reuters) - New European Commission President Jean-Claude Juncker, in a change of tack, has decided to keep responsibility for medicines in the Commission's division for health, rather than switching it to its industry unit. The supervision of medicines is a hot topic in Europe, following a series of rows over access to clinical trial data, and the original plan to move it from the directorate general (DG) for Health and Consumers to the DG for Enterprise and Industry triggered protests. ... via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment